Caricamento...

Clinical Efficacy Evaluation of Sirolimus in Congenital Hyperinsulinism

BACKGROUND: Congenital hyperinsulinism (CHI) is a rare and life-threatening genetic disorder. Sirolimus as a mammalian target of rapamycin inhibitor may be helpful in patients with CHI who do not respond well to other treatments including diazoxide and octreotide. However, the safety and efficacy of...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Int J Endocrinol
Autori principali: Hashemian, Somayyeh, Jafarzadeh Esfehani, Reza, Karimdadi, Siroos, Vakili, Rahim, Zamanfar, Daniel, Sahebkar, Amirhossein
Natura: Artigo
Lingua:Inglês
Pubblicazione: Hindawi 2020
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7396056/
https://ncbi.nlm.nih.gov/pubmed/32774365
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/7250406
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !